MLH1 as a Direct Target of MiR-155 and a Potential Predictor of Favorable Prognosis in Pancreatic Cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Gastrointestinal Surgery

• Publication date

  2013-05-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11605-013-2230-5PMID 23715647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic cancer.

  2013cited by this paper
• Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K‐Ras transgenic mouse model of pancreatic cancer

  2012cited by this paper
• Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer

  2011cited by this paper
• Prognostic Implications of Lymph Node Metastases in Carcinoma of the Body and Tail of the Pancreas

  2011cited by this paper
• Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic Cancer

  2011cited by this paper
• Down-Regulation of DNA Mismatch Repair Enhances Initiation and Growth of Neuroblastoma and Brain Tumour Multicellular Spheroids

  2011cited by this paper
• Therapeutic Targeting of the DNA Mismatch Repair Pathway

  2010cited by this paper
• Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: Clinical and prognostic significance

  2010cited by this paper
• Modulation of mismatch repair and genomic stability by miR-155

  2010cited by this paper
• Pancreatic cancer.

  2010cited by this paper
• Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

  2010cited by this paper
• MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition

  2009cited by this paper
• Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer.

  2009cited by this paper
• Clinical and pathologic prognostic factors for curative resection for pancreatic cancer.

  2008cited by this paper
• Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines

  2008cited by this paper
• DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

  2008cited by this paper
• Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2

  2008cited by this paper
• Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.

  2008cited by this paper
• Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late‐onset breast carcinoma: clinical and prognostic significance

  2008cited by this paper
• Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

  2007cited by this paper
• Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40

  2006cited by this paper
• Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid endometrial adenocarcinoma

  2006cited by this paper
• Expression profiling identifies microRNA signature in pancreatic cancer

  2006cited by this paper
• HOXA5 regulates hMLH1 expression in breast cancer cells.

  2006cited by this paper
• MLH1 mismatch repair gene product is associated with apoptotic potential of urothelial bladder carcinomas.

  2006cited by this paper
• Defective DNA Mismatch Repair in Long-Term (≥3 Years) Survivors with Pancreatic Cancer

  2005cited by this paper
• Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma

  2005cited by this paper
• Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis?

  2004cited by this paper
• Prognostic Implications of hMLH1 and p53 Immunohistochemical Status in Right-Sided Colon Cancer

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features.

  2003cited by this paper
• Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients.

  2003cited by this paper
• Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability

  2003cited by this paper
• Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers.

  2003cited by this paper
• Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.

  2000cited by this paper
• Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival.

  2000cited by this paper

• Emerging roles of non-coding RNAs in the tumor microenvironment of pancreatic cancer: Focusing on current challenges and future directions.

  2026cites this paper
• Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer.

  2025cites this paper
• Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma.

  2024cites this paper
• MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle

  2024cites this paper
• MLH1 Inhibits Metastatic Potential of Pancreatic Ductal Adenocarcinoma via Downregulation of GPRC5C.

  2024cites this paper
• Assessing the toxicity of pesticides exposure on hepatic miRNA-target gene alterations in rat liver tissues via molecular and integrated network bioinformatics analysis.

  2024cites this paper
• Microbiome and MicroRNA or Long Non-Coding RNA—Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review

  2021cites this paper
• MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3.

  2019cites this paper
• Simultaneous downregulation of miR‐21 and miR‐155 through oleuropein for breast cancer prevention and therapy

  2018cites this paper
• MicroRNA-155-5p suppresses the migration and invasion of lung adenocarcinoma A549 cells by targeting Smad2

  2018cites this paper
• An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma

  2018cites this paper
• Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704

  2018influential citation
• Expression of hMLH1 and hMSH2 proteins in ameloblastomas and tooth germs

  2018cites this paper
• Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy

  2017cites this paper
• Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

  2017cites this paper
• MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

  2017cites this paper
• MiR-155 Promotes Uveal Melanoma Cell Proliferation and Invasion by Regulating NDFIP1 Expression

  2017cites this paper
• Oncogenic role of microRNA‐155 in mycosis fungoides: an in vitro and xenograft mouse model study

  2017cites this paper
• Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively

  2017cites this paper
• Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.

  2017cites this paper
• MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis

  2017cites this paper
• Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language

  2016cites this paper
• MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer

  2016cites this paper
• MicroRNA in pancreatic cancer

  2016cites this paper
• MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells

  2016cites this paper
• Support Vector Machine Based on microRNA Expression Profiles to Predict Histological Origin of Ampullary Carcinoma: Case Report of a Patient Affected From Adenocarcinoma of the Papilla of Vater With Lynch Syndrome

  2016cites this paper
• Regulation of DNA repair by non-coding miRNAs

  2016cites this paper
• Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma.

  2015cites this paper
• Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer

  2015cites this paper
• MicroRNA-155 expression is independently predictive of outcome in chordoma

  2015cites this paper
• Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer.

  2015cites this paper
• RNA-directed repair of DNA double-strand breaks.

  2015cites this paper
• MiR-421, miR-155 and miR-650: emerging trends of regulation of cancer and apoptosis.

  2014cites this paper
• The Pivotal Role of microRNA‐155 in the Control of Cancer

  2014cites this paper
• Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer.

  2014cites this paper
• Pathology, genetic alterations, and targets of differentially expressed microRNAs in pancreatic cancer

  2014cites this paper
• International Journal of Molecular Sciences the Miracle in Pancreatic Cancer by Mirnas: Tiny Angels or Devils in Disease Progression

  year unknowncites this paper